Becton Dickinson and Company Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (34)

Latest Posts

About This Stock More About This Stock
Becton, Dickinson (BDX) Beats On Q4 Earnings, Guidance Solid
Article By: Zacks Investment Research
Thursday, November 2, 2017 11:08 AM EST
The company expects fiscal 2018 revenues to increase 5% to 6%. The company expects adjusted earnings per share between $10.55 and $10.65 on a stand-alone basis, which represents growth of approximately 12%.
In this article: BDX Also: LMNX, ISRG, PETS
Read
Becton Dickinson (BDX): A Quality Dividend Aristocrat With Double-Digit Payout Growth
Article By: Simply Safe Dividends
Tuesday, June 20, 2017 3:10 PM EST
Becton Dickinson is a high quality healthcare company with a number of long-term growth opportunities. Its acquisitions of CareFusion and C.R. Bard significantly expand its addressable market.
In this article: BDX
Read
Becton Dickinson: What Are Investors To Think Of The Massive $24 Billion C.R. Bard Takeover?
Article By: SureDividend
Wednesday, May 3, 2017 11:00 AM EST
Becton, Dickinson has found a high-quality business that can leverage its existing capabilities, as well as give it a presence in new areas. The huge buyout of CR Bard should bring about significant growth opportunities.
In this article: BDX Also: BCR
Read
CR Bard Inc. To Be Acquired By Becton Dickinson And Co. For $24 Billion
Article By: Lorimer Wilson
Monday, April 24, 2017 10:42 AM EST
CR Bard Inc. has agreed to be acquired by fellow medical devices giant Becton Dickinson and Co. for $24 billion in cash and stock.
In this article: BCR, BDX
Read
Premarket Biotech Digest – BDX Finalizes Acquisition Deal, VNLPF Receives CRL, EYEG Files S-1
Article By: KKD Healthcare Analytics
Monday, April 24, 2017 10:03 AM EST
Johnson & Johnson announced results from a Phase 2 clinical trial assessing the triple combination ofOlysio (simeprevir), C.R. Bard Inc. and Becton Dickinson finalize the deal for buying Bard.
In this article: BCR, JNJ, MRK, NVO, VNLPF, XOMA, EYEG, ARGNF, BDX
Read

PARTNER HEADLINES

Latest Tweets for $BDX

No tweets yet!